Preoperative Glycemic Control on Total Joint Arthroplasty Patient-Perceived Outcomes and Hospital Costs.

Autor: Lavernia CJ; The Center for Advanced Orthopedics at Larkin Community Hospital, South Miami, Florida., Heiner AD; The Center for Advanced Orthopedics at Larkin Community Hospital, South Miami, Florida; Arthritis Surgery Research Foundation, South Miami, Florida., Villa JM; The Center for Advanced Orthopedics at Larkin Community Hospital, South Miami, Florida; Arthritis Surgery Research Foundation, South Miami, Florida., Alcerro JC; The Center for Advanced Orthopedics at Larkin Community Hospital, South Miami, Florida; Arthritis Surgery Research Foundation, South Miami, Florida., Rossi MD; Department of Physical Therapy, Florida International University, Miami, Florida.
Jazyk: angličtina
Zdroj: The Journal of arthroplasty [J Arthroplasty] 2017 Jan; Vol. 32 (1), pp. 6-10. Date of Electronic Publication: 2016 Jul 15.
DOI: 10.1016/j.arth.2016.07.002
Abstrakt: Background: The purpose of this study was to determine the influence of preoperative glycemic control in diabetic patients undergoing a primary total hip or knee arthroplasty. We wanted to study patient-perceived outcomes in the medium term, the length of stay, hospital costs, and rate of short-term postoperative complications.
Methods: One hundred twenty consecutive primary total joint arthroplasties (TJAs) performed in type 2 diabetic patients were stratified into 2 groups representing optimal and suboptimal preoperative glycemic control, based on serum levels of glycated hemoglobin (HbA 1c ), and those groups compared.
Results: The mean follow-up time was 5.9 years (range, 2.1-10.7 years). Both groups demonstrated improvement in all patient-perceived outcome measures after TJA, with no significant difference detected in any change of a measure between the groups. No significant difference was detected in the length of stay, hospital costs, or rate of short-term postoperative complications between the groups.
Conclusion: Preoperative glycemic control in type 2 diabetic patients undergoing TJA did not affect patient-perceived outcomes in the medium term. Optimal vs suboptimal glycemic control in these patients also had no effect on the length of stay, hospital costs, or rate of short-term postoperative complications.
(Copyright © 2016 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: